Universe Pharmaceuticals (UPC) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $0.01.
- Universe Pharmaceuticals' Debt to Equity fell 9599.47% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year decrease of 9599.47%. This contributed to the annual value of $0.01 for FY2025, which is 9599.47% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Debt to Equity stood at $0.01 for Q3 2025, which was down 9599.47% from $0.2 recorded in Q3 2024.
- Universe Pharmaceuticals' 5-year Debt to Equity high stood at $0.28 for Q1 2024, and its period low was $0.0 during Q3 2022.
- Over the past 5 years, Universe Pharmaceuticals' median Debt to Equity value was $0.0 (recorded in 2021), while the average stood at $0.08.
- In the last 5 years, Universe Pharmaceuticals' Debt to Equity tumbled by 10000.0% in 2021 and then skyrocketed by 10123413.77% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Debt to Equity (Quarter) stood at $0.0 in 2021, then crashed by 77.21% to $0.0 in 2022, then surged by 104.93% to $0.0 in 2023, then skyrocketed by 101234.14% to $0.2 in 2024, then tumbled by 95.99% to $0.01 in 2025.
- Its Debt to Equity stands at $0.01 for Q3 2025, versus $0.2 for Q3 2024 and $0.28 for Q1 2024.